DK11391A - Alkoxy-4(1h)-pyridonderivater og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse - Google Patents

Alkoxy-4(1h)-pyridonderivater og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse Download PDF

Info

Publication number
DK11391A
DK11391A DK011391A DK11391A DK11391A DK 11391 A DK11391 A DK 11391A DK 011391 A DK011391 A DK 011391A DK 11391 A DK11391 A DK 11391A DK 11391 A DK11391 A DK 11391A
Authority
DK
Denmark
Prior art keywords
alkoxy
derivatives
pyridon
preparation
acceptable salts
Prior art date
Application number
DK011391A
Other languages
English (en)
Other versions
DK11391D0 (da
DK174097B1 (da
Inventor
Julian Aranda
Johannes Hartenstein
Reinhard Reck
Christoph Schaechtele
Claus Rudolph
Hartmut Osswald
Guenter Weinheimer
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DK11391D0 publication Critical patent/DK11391D0/da
Publication of DK11391A publication Critical patent/DK11391A/da
Application granted granted Critical
Publication of DK174097B1 publication Critical patent/DK174097B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK199100113A 1988-08-06 1991-01-23 2-Substituerede 5-alkoxy-4(1H)-pyridonderivater og farmakologisk accepteble salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat samt derivaternes anvendelse DK174097B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3826846A DE3826846A1 (de) 1988-08-06 1988-08-06 Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE3826846 1988-08-06
PCT/EP1989/000927 WO1990001477A1 (de) 1988-08-06 1989-08-04 Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
EP8900927 1989-08-04

Publications (3)

Publication Number Publication Date
DK11391D0 DK11391D0 (da) 1991-01-23
DK11391A true DK11391A (da) 1991-01-23
DK174097B1 DK174097B1 (da) 2002-06-10

Family

ID=6360419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100113A DK174097B1 (da) 1988-08-06 1991-01-23 2-Substituerede 5-alkoxy-4(1H)-pyridonderivater og farmakologisk accepteble salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat samt derivaternes anvendelse

Country Status (18)

Country Link
US (2) US5185352A (da)
EP (2) EP0427765B1 (da)
JP (1) JP2878361B2 (da)
KR (1) KR920006779B1 (da)
CN (1) CN1040193A (da)
AT (1) ATE188469T1 (da)
AU (1) AU627766B2 (da)
CA (1) CA1340608C (da)
DD (1) DD284003A5 (da)
DE (2) DE3826846A1 (da)
DK (1) DK174097B1 (da)
ES (1) ES2144391T3 (da)
GR (1) GR3033072T3 (da)
HU (1) HUT56545A (da)
NO (1) NO177785C (da)
PT (1) PT91351B (da)
WO (1) WO1990001477A1 (da)
ZA (1) ZA895969B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822786A (en) * 1986-07-01 1989-04-18 Kaken Pharmaceutical Co., Ltd. Cephalosporin compounds, and antibacterial agents
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5674883A (en) * 1992-02-07 1997-10-07 Roussel Uclaf Derivatives of pyridone, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
JP2002531511A (ja) * 1998-12-07 2002-09-24 エコスマート テクノロジーズ，インコーポレーテッド シグナル伝達調節物質と天然植物精油を用いた癌治療薬配合物および方法
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6906068B1 (en) 1999-05-19 2005-06-14 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
US6660885B2 (en) 2000-03-13 2003-12-09 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
US6693121B2 (en) 2000-04-05 2004-02-17 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
PT1268463E (pt) 2000-04-05 2005-05-31 Pharmacia Corp 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
JP2005519866A (ja) 2001-10-03 2005-07-07 ファルマシア・コーポレーション 凝固カスケードの選択阻害に有用な６員複素環式化合物
EP1432687A2 (en) 2001-10-03 2004-06-30 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
WO2008116301A1 (en) * 2007-03-28 2008-10-02 Apotex Technologies Inc. Fluorinated derivatives of deferiprone
CN102014904B (zh) 2008-04-25 2013-02-06 阿普泰克斯科技公司 具有适口味道的去铁酮液体配制品
AR076540A1 (es) 2009-05-01 2011-06-22 Eurand Inc Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de analgesicos no- opioides y opioides, forma de dosificacion. metodo de preparacion. metodo para tratar dolor
AU2010268666B2 (en) 2009-07-03 2014-07-24 Apotex Inc. Fluorinated derivatives of 3-Hydroxypyridin-4-ones
JP6358639B2 (ja) * 2015-04-24 2018-07-18 塩野義製薬株式会社 ６員複素環誘導体およびそれらを含有する医薬組成物
JP6692113B2 (ja) * 2016-10-21 2020-05-13 塩野義製薬株式会社 ６員複素環誘導体を含有する医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA554715A (en) * 1958-03-18 Boesch Roger Ethers and thioethers and processes for their preparation
US2965641A (en) * 1959-07-06 1960-12-20 Searle & Co Derivatives of 1-(2-aminoethyl)-5-alkoxy-4-pyridones
CA978958A (en) * 1971-10-04 1975-12-02 Haydn W.R. Williams Substituted pyranones and -pyridones and process of manufacture
JPS59110674A (ja) * 1982-12-16 1984-06-26 Ss Pharmaceut Co Ltd ピリジン誘導体及びその製造法
JPS59110675A (ja) * 1982-12-16 1984-06-26 Ss Pharmaceut Co Ltd ピリジン誘導体及びその製造方法
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4822786A (en) * 1986-07-01 1989-04-18 Kaken Pharmaceutical Co., Ltd. Cephalosporin compounds, and antibacterial agents
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
DD284003A5 (de) 1990-10-31
GR3033072T3 (en) 2000-08-31
US5322844A (en) 1994-06-21
ATE188469T1 (de) 2000-01-15
ES2144391T3 (es) 2000-06-16
CN1040193A (zh) 1990-03-07
ZA895969B (en) 1990-05-30
JPH04500958A (ja) 1992-02-20
NO910444L (no) 1991-02-05
KR900701755A (ko) 1990-12-04
NO177785B (no) 1995-08-14
HUT56545A (en) 1991-09-30
EP0427765B1 (de) 2000-01-05
NO177785C (no) 1995-11-22
EP0427765A1 (de) 1991-05-22
PT91351B (pt) 1997-01-31
EP0354495A1 (de) 1990-02-14
JP2878361B2 (ja) 1999-04-05
DK11391D0 (da) 1991-01-23
PT91351A (pt) 1990-03-08
DE58909865D1 (de) 2000-02-10
AU4048989A (en) 1990-03-05
DE3826846A1 (de) 1990-02-08
CA1340608C (en) 1999-06-22
WO1990001477A1 (de) 1990-02-22
US5185352A (en) 1993-02-09
HU894581D0 (en) 1991-07-29
AU627766B2 (en) 1992-09-03
KR920006779B1 (ko) 1992-08-17
DK174097B1 (da) 2002-06-10
NO910444D0 (no) 1991-02-05

Similar Documents

Publication Publication Date Title
DK11391A (da) Alkoxy-4(1h)-pyridonderivater og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse
DK0397060T3 (da) Maleinimidderivater og deres anvendelse som lægemidler
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
AP9901435A0 (en) Bicycle heteroaromatic compounds as protein tyrosine kinase inhibitors.
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
GR3001738T3 (en) Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments
EP0119161A3 (en) Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use
EP0434057A3 (en) Indolocarbazole derivatives, processes for their preparation and their use
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
ES2038813T3 (es) Derivados de indolocarbazol, procedimientos para su produccion y su uso como medicamentos.
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
DK573788D0 (da) Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
DK395788A (da) Oploeselige silybinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO872812L (no) 4-nitrogensubstituerte isokinolinolforbindelser med terapeutisk aktivitet og fremgangsmŸte for deres fremstilling.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DK478485A (da) 4-oxo-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
DK65691D0 (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler
DK314587A (da) 1,4-dihydropyridinderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
NO885058L (no) 6-oxoprostaglandin-e-derivater, fremgangsmaater for fremstilling av disse og deres farmasoeytiske anvendelse.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK